Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
02/2000
02/15/2000US6025361 Effective pde iv inhibitors, asthma
02/15/2000US6025356 Powerful dopaminergic compounds, low level of side effects exhibited.
02/15/2000US6025332 Method for treating low circulating levels of sex hormone steroids associated with aging using IGF or IGF/IGFBP-3
02/15/2000US6025193 Dna construct of promoter, antisense oligonucleotide which binds to messenger rna in the translational start site region encoding the receptor, and a polyadenylation signal sequence; for improved selectivity in treatment
02/15/2000US6025180 Asp1
02/15/2000US6025166 Human trk receptors and neurotrophic factor inhibitors
02/15/2000US6025147 Inhibitors of interleukin-1 β converting enzyme
02/15/2000US6024977 Covalent polar lipid conjugates with neurologically active compounds for targeting
02/15/2000US6024957 Immunomodulators and methods for the prevention and reversal of organ transplant rejection using same
02/15/2000CA2197739C 1,4-dihydropyridine compounds
02/15/2000CA2109585C Isoxazole and isothiazole compounds that enhance cognitive function
02/15/2000CA2105114C Monohydrate of 5-(2-(4-(1,2 benzisothiazol-3-yl)-1- piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one hydrochloride
02/15/2000CA2058398C 1,4 benzothiazine-2-acetic acid derivatives, processes for production thereof
02/15/2000CA2006008C Method for making synthetic oligonucleotides which bind specifically to target sites on duplex dna molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use
02/12/2000CA2248989A1 Novel compounds
02/10/2000WO2000006767A1 Genetic polymorphisms in the human neurokinin 2 receptor gene and their use in diagnosis and treatment of diseases
02/10/2000WO2000006730A2 Human cytoskeletal proteins
02/10/2000WO2000006709A1 Human protein kinase h2lau20
02/10/2000WO2000006698A1 98 human secreted proteins
02/10/2000WO2000006589A1 Prostate derived ets factor
02/10/2000WO2000006580A1 Pyridobenzothiazine derivatives and process for producing the same
02/10/2000WO2000006579A2 Pyrrolo[2,1-b][1,3]benzothiazepines with atypical antipsychotic activity
02/10/2000WO2000006578A1 Pyridobenzoxazine derivatives and process for producing the same
02/10/2000WO2000006572A1 Bensoquinolizine derivatives and process for producing the same
02/10/2000WO2000006571A1 Pyrroloquinoline derivatives and process for producing the same
02/10/2000WO2000006567A1 3-(4-amino-5-ethylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridine
02/10/2000WO2000006561A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
02/10/2000WO2000006558A1 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them
02/10/2000WO2000006552A1 4-phenyl- and 4,5-diphenylimidazole derivatives, preparation and therapeutic application
02/10/2000WO2000006545A1 High affinity ligands for nociceptin receptor orl-1
02/10/2000WO2000006544A1 Cyclic amine derivatives and process for the preparation thereof
02/10/2000WO2000006254A2 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
02/10/2000WO2000006203A1 Dna cytokine vaccines and use of same for protective immunity against multiple sclerosis
02/10/2000WO2000006187A2 Modulation of apoptosis
02/10/2000WO2000006185A2 Methods of using lanreotide, a somatostatin analogue
02/10/2000WO2000006183A1 C7F2-A NOVEL POTASSIUM CHANNEL β-SUBUNIT
02/10/2000WO2000006174A1 Methods for increasing cytidine levels in vivo and treating cytidine-dependent human diseases
02/10/2000WO2000006171A1 Antioxidant composition and method of treating diseases using same
02/10/2000WO2000006161A1 Prevention of migraine recurrence
02/10/2000WO2000006160A1 Treating depression with a combination of fluoxetine (prozac), pindolol (visken) and buspirone (buspar)
02/10/2000WO2000006159A1 Heterocyclic sulphonamide derivatives
02/10/2000WO2000006158A1 Heterocyclyl sulphonamide derivatives
02/10/2000WO2000006157A1 Sulphonamide derivatives
02/10/2000WO2000006156A1 Amide, carbamate, and urea derivatives
02/10/2000WO2000006149A1 Sulfonamide derivatives
02/10/2000WO2000006148A1 Sulphonamide derivatives
02/10/2000WO2000006145A1 Methods for treating conditions modulated by lactosylceramide
02/10/2000WO2000006140A2 Use of moclobemide for treating certain phsychiatric and medical disorders
02/10/2000WO2000006139A2 Use of moclobemide and metabolites for treating and preventing substance abuse
02/10/2000WO2000006138A2 Use of moclobemide for treating pain and other diseases
02/10/2000WO2000006137A2 Glucocorticoid-selective anti-inflammatory agents
02/10/2000WO2000006135A2 Cholinergic agents in the treatment of presbyopia
02/10/2000WO2000006121A1 Medicinal aerosol formulations
02/10/2000WO2000006085A2 Compounds and methods
02/10/2000WO2000006082A2 Treatment of anxiety disorders
02/10/2000WO2000000825A3 Detection and modulation of cellular immunity to immune privileged antigens
02/10/2000WO2000000510A8 Growth factor modulators
02/10/2000WO2000000489A3 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands
02/10/2000WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors
02/10/2000WO1999060024A9 Methods for amyloid removal using anti-amyloid antibodies
02/10/2000WO1999049039A3 GFRα3 AND ITS USES
02/10/2000WO1999049038A3 Human calcium-binding proteins
02/10/2000WO1999041376A3 Retinoblastoma protein complexes and retinoblastoma interacting proteins
02/10/2000WO1999030548A3 Method for the preparation of citalopram
02/10/2000DE19835918A1 Neue antikonvulsiv wirkende 4-Amino-1-aryl-pyridin-2-one und Verfahren zu deren Herstellung New anticonvulsant action of 4-amino-1-aryl-pyridin-2-one and processes for their preparation
02/10/2000DE19835324A1 Cyclopentabenzofuran-Derivate und ihre Verwendung Cyclopentabenzofuran derivatives and their use
02/10/2000CA2339301A1 Hdpbo81 nucleic acids and polypeptides
02/10/2000CA2339099A1 Sulfonamide derivatives
02/10/2000CA2339096A1 Modulation of apoptosis
02/10/2000CA2339093A1 Cholinergic agents in the treatment of presbyopia
02/10/2000CA2339091A1 Sulphonamide derivatives
02/10/2000CA2338930A1 Heterocyclic sulphonamide derivatives
02/10/2000CA2338916A1 Amide, carbamate, and urea derivatives
02/10/2000CA2338864A1 Sulphonamide derivatives
02/10/2000CA2338745A1 Heterocyclyl sulphonamide derivatives
02/10/2000CA2338740A1 Treatment of anxiety disorders
02/10/2000CA2338697A1 Compounds and methods
02/10/2000CA2338694A1 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them
02/10/2000CA2338330A1 Use of moclobemide for treating certain phsychiatric and medical disorders
02/10/2000CA2338327A1 Use of moclobemide for treating pain and other diseases
02/10/2000CA2338326A1 Use of moclobemide and metabolites for treating and preventing substance abuse
02/10/2000CA2338019A1 Prostate derived ets factor
02/10/2000CA2336549A1 Methods for treating conditions modulated by lactosylceramide
02/10/2000CA2335656A1 Human cytoskeletal proteins
02/10/2000CA2335654A1 Methods of using a somatostatin analogue
02/10/2000CA2335643A1 C7f2-a novel potassium channel .beta.-subunit
02/10/2000CA2335077A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
02/09/2000EP0978517A2 Triazolopurines, process for their preparation and their use as medicaments
02/09/2000EP0978287A1 MEDICINAL COMPOSITION CONTAINING gp34 BINDING INHIBITOR AS THE ACTIVE INGREDIENT
02/09/2000EP0977860A1 Ngf variants
02/09/2000EP0977859A1 The neurotrophic factor nnt-1
02/09/2000EP0977848A1 Human theta subunit of the gaba-a receptor
02/09/2000EP0977777A1 A novel th2-specific gene
02/09/2000EP0977776A2 A PURIFIED 20 kDa PRESENILIN 2 C-TERMINAL FRAGMENT AND METHODS OF SCREENING FOR COMPOUNDS THAT INHIBIT PROTEOLYSIS OF PRESENILIN 2
02/09/2000EP0977759A1 Crf antagonistic thiophenopyridines
02/09/2000EP0977758A1 Spiro-azacyclic derivatives and their use as therapeutic agents
02/09/2000EP0977757A1 9,10-diazatricyclo 4.2.1.1?2,5 ]decane and 9,10-diazatricyclo 3.3.1.1?2,6 ]decane derivatives having analgesic activity
02/09/2000EP0977755A1 Heterocyclic compounds and their preparation and use
02/09/2000EP0977753A1 Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension
02/09/2000EP0977751A1 Somatostatin agonists
1 ... 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 ... 1833